ChrisKey Biomedical Technology

ChrisKey Biomedical Technology is a precision medicine and medical device company specializing in circulating tumor cell (CTC) detection and infection control. The company's core offerings include the ChrisKey CTC platform, which utilizes high-sensitivity enrichment and identification techniques for liquid biopsy applications in oncology, and the Bio-Kil antibacterial technology, designed to eliminate pathogens in hospital environments. ChrisKey's solutions support cancer diagnosis, treatment monitoring, and the reduction of nosocomial infections in intensive care and surgical settings. With operations in Taiwan and Shanghai, the company serves a global network of medical institutions and pharmaceutical partners.